ConductScience.org, home

Library / Trial comparisons

Intensive Protocol vs Usual Care Protocol: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.3560.3430.369wilsonClinicalTrials.gov
Risk in group 20.3640.350.377wilsonClinicalTrials.gov
Risk difference, group 1 minus group 2-0.0077-0.02660.0112newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 20.9790.9291.03logClinicalTrials.gov
Odds ratio, group 1 over group 20.9670.8911.05logClinicalTrials.gov
Number needed to treat, for one fewer death from any cause on Intensive Protocol than on Usual Care Protocol130from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Group 2 names the comparator: usual care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Intensive Protocol
Facility randomized to follow the intensive nutritional supplement protocol~Nutritional Supplement: Selection of which supplement to give to the patients will be left to the dialysis unit's governing body as this study is not interested in a specific supplement's effect on nutrient restoration and subsequent outcomes but rather on oral replacement of amino acids regardless of the agent used.
1,8275,133EG001ClinicalTrials.gov
Group 2Usual Care Protocol
Facility randomized to follow the usual care nutritional supplement protocol~Nutritional Supplement: Selection of which supplement to give to the patients will be left to the dialysis unit's governing body as this study is not interested in a specific supplement's effect on nutrient restoration and subsequent outcomes but rather on oral replacement of amino acids regardless of the agent used.
1,7324,763EG000ClinicalTrials.gov

Harm 2

FieldValueSource
What it countsTotal, all-cause mortalityClinicalTrials.gov
Time frameClinicalTrials.gov

Trial 8

FieldValueSource
TitleHealth Effects of oraL Protein Supplements in HD (The HELPS-HD Trial)ClinicalTrials.gov
NCT numberNCT02933151ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsEnd Stage Renal DiseaseClinicalTrials.gov
InterventionsNutritional SupplementClinicalTrials.gov
Lead sponsorDialysis Clinic, Inc.ClinicalTrials.gov
Results first posted2024-11-05ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT02933151?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.